CORE
šŗš¦Ā
Ā make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
11 research outputs found
Metastatic castrationāsensitive prostate cancer: Abiraterone, docetaxel, orā¦
Author
Ahmad AE
Boeve LMS
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy
Author
Boeve LMS
Verhagen Paul
Vis AN
Publication venue
Publication date
01/01/2019
Field of study
No full text
EUR Research Repository
Longāterm outcomes of combining prostate brachytherapy and metastasisādirected radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study
Author
Boeve LMS
Epstein JI
Leung D
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Treatment in hormone-sensitive metastatic prostate cancer: factors to consider when personalizing therapy
Author
Boeve LMS
Huggins C
James ND
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
Author
Boeve LMS
Delaere KPJ
+8Ā more
Hulshof M
Twisk JWR
van Andel G
van Moorselaar RJA
Verhagen Paul
Vis AN
Witjes WPJ
Zwinderman AH
Publication venue
'Elsevier BV'
Publication date
01/01/2019
Field of study
No full text
EUR Research Repository
Metastatic hormone sensitive prostate cancer: local treatment strategies
Author
A Heidenreich
B Loppenberg
+26Ā more
C Fuccio
C Gratzke
CC Parker
CG Rusthoven
CJ Sweeney
E Rapiti
F Poelaert
F Preisser
F Preisser
FE Lecouvet
ID Davis
K Fizazi
LMS Boeve
N Fossati
P Ost
R Badwe
R Satkunasivam
RN Kaplan
S Burdett
SA Kwee
SH Culp
SR Leyh-Bannurah
SS McAllister
T Steuber
WL Ong
Y Cho
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Predicting early outcomes in patients with intermediateā and highārisk prostate cancer using prostateāspecific membrane antigen positron emission tomography and magnetic resonance imaging
Author
Boeve LMS
Bouvet V
+28Ā more
Briganti A
Cimino S
Culp SH
Egevad L
Eiber M
Emmett L
Feng TS
Gandaglia G
Hofman MS
Huang Y
Hull GW
Jansen BHE
Kjolhede H
Knipper S
Leeuwen PJ
Meijer D
Mohler JL
Mottet NBJ
Padhani AR
Parker CC
Perera M
Ploussard G
Preisser F
Ravert HT
Rayn KN
Roberts MJ
Weaver JK
Wiegel T
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts
Author
AP Hoyle
C Nanni
+37Ā more
C Parker
CC Parker
CJ Sweeney
Collaboration GB of DC
DM Schuster
DR Berthold
E MartĆn-Merino
ES Antonarakis
F Bray
FG Rick
G Gravis
HI Scher
ID Davis
IMJ Thompson
J Lehmann
JL Mohler
JS de Bono
K Fizazi
KA Touijer
KN Chi
L Klotz
LMS Boeve
M Bolla
M Perera
N Mottet
N Mottet
ND James
ND Shore
NW Clarke
PC Albertsen
R Li
RZ Szmulewitz
S Gillessen
T Karantanos
T Vag
T Wiegel
TM Beer
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
Author
A Josefsson
AB Weiner
+54Ā more
AJ Armstrong
AJ Armstrong
AP Hoyle
AS Fauci
AW Hahn
AW Wyatt
C Huggins
C Kongseang
C Tran
CC Parker
CE Kyriakopoulos
CG Craddock
CJ Sweeney
CJD Wallis
CL Martel
CM Tangen
E Castro
ES Antonarakis
F Bray
F Saad
FC Hamdy
G Attard
G Boysen
G Gravis
G Gravis
ID Davis
IF Tannock
J Mahil
J Mateo
JS de Bono
JT Helgstrand
K Fizazi
K Fizazi
KN Chi
L Yin
LMS Boeve
M Pascale
M Perera
M Westerberg
MR Smith
MR Sydes
MS Darshan
ND James
ND James
NJ Sathianathen
NW Clarke
P Rawla
RJ Auchus
S Burdett
S Gillessen
S Narita
SJ Freedland
W Abida
YG Tan
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
Author
A Cano
A Dragomir
+90Ā more
A Liede
A Sciarra
AJ Salonen
AJ Salonen
AJ Salonen
AL Potosky
AM Evens
B Tombal
C Cattrini
C Huggins
C Jin
C Schulman
CC Parker
CE Kyriakopoulos
CJ Nelson
CJ Sweeney
CS Higano
D Brungs
D Eknoyan
D Watkins Bruner
D Wittmann
DL Hershman
DR Ziehr
F Calais da Silva
F Hering
F Recine
FB Thomsen
FE Calais da Silva
FJ Fowler Jr.
G Bartsch
G Corona
G Corona
GL Shaw
GM Duchesne
H Koga
H Lilja
H Yamanaka
HI Scher
HT Tsai
J de Leval
J Irani
JD Sammon
JE Damber
JF Langenhuijsen
JL Mohler
JM Crook
JN Graff
K Fizazi
K Miller
KT Nead
KT Nead
L Boccon-Gibod
L Klotz
L Klotz
LH Klotz
LMS Boeve
M Gleave
M Hussain
M Hussain
M Hussain
M Organ
M Shim
N Bruchovsky
N Bruchovsky
N Mondaini
N Mottet
ND James
NW Clarke
P Cornford
P Fayers
P Sooriakumaran
PA Abrahamsson
PC Verhagen
PD Cleary
PL Nguyen
RL Siegel
S Li
S Magnan
S Niraula
S OāFarrell
SGR McDuff
SL Goldenberg
TA Stamey
TE Botrel
U Tunn
UE Studer
V Muralidhar
X Bonfill
Y Arai
YN Wong
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
1
2